On this page
Bio-Synergy targets £3-5 million in first-year India sales with DNA + Epigenetics testing kit launch
Bio-Synergy launched the kit in Mumbai with partner Kynora Life Sciences LLP, with packages priced between ₹25,000 and ₹85,000. The packages will be sold directly through its website.
One email each morning: the day’s top moves in Indian retail, why each matters and what to watch. Free. Stop any time.
The numbers
Figures from Business Standard Companies & Industry,
| Kynora reach target during FY28: | 10,000 people |
|---|---|
| India supplements market size: | ₹8,000 crore |
| India supplements category annual growth: | 14 per cent |
Why it matters for the brand
Bio-Synergy is selling its DNA + Epigenetics Kit at ₹25,000 to ₹85,000 only through its own website for now, so supplement and wellness retailers should prepare for wider availability by end of October and decide whether to stock it or partner.
What to track next
- Announcement of new retail, clinic or e-commerce channels by end of October
- Any first-year sales update against the £3-5 million target
- Launch of cheaper or entry-level packages below ₹25,000
- Rival genomics or supplement brands launching comparable DNA or epigenetics products in India
- Regulatory notices, advisories or media scrutiny on genetic testing claims or data privacy